These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6261052)

  • 1. [Evidence for the persistence of Epstein-Barr-virus in the parotid gland (author's transl)].
    Wilmes E; Wolf H
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):7-10. PubMed ID: 6261052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological role of human palatine tonsil in Epstein-Barr virus persistence.
    Hirao M; Harabuchi Y; Kataura A; Imai S; Osato T
    Acta Otolaryngol Suppl; 1996; 523():158-60. PubMed ID: 9082768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J; Hansmann ML; Rajewsky K; Küppers R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Epstein-Barr virus-related diseases.
    Linde A
    Scand J Infect Dis Suppl; 1996; 100():83-8. PubMed ID: 8860358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis.
    Britton S; Andersson-Anvret M; Gergely P; Henle W; Jondal M; Klein G; Sandstedt B; Svedmyr E
    N Engl J Med; 1978 Jan; 298(2):89-92. PubMed ID: 201839
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of Epstein-Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriers.
    Oosterveer MA; Markusse HM; Lennette ET; Zou JZ; Bolhuis RL; Gratama JW
    J Med Virol; 1993 Dec; 41(4):261-9. PubMed ID: 8106859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-specific serology in immunologically compromised individuals.
    Henle W; Henle G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4222-5. PubMed ID: 6272966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Epstein-Barr virus in the parotid gland.
    Wolf H; Haus M; Wilmes E
    J Virol; 1984 Sep; 51(3):795-8. PubMed ID: 6088802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.
    Fukayama M; Hayashi Y; Iwasaki Y; Chong J; Ooba T; Takizawa T; Koike M; Mizutani S; Miyaki M; Hirai K
    Lab Invest; 1994 Jul; 71(1):73-81. PubMed ID: 8041121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.